C1orf116 is a novel EMT biomarker for prostate cancer, and our study showed 17-fold and 24-fold downregulation of this gene in taxane-resistant prostate cancer subtypes DUTXR and PC-3TXR, respectively. Here, C1orf116 is linked to prostate cancer.